📖 Approx. 8 min ／ Updated 2026.07.26
ENT clinics experience significant patient volume fluctuations due to seasonality, making year-round patient acquisition strategies essential for stable management. This article is for owners considering the sale or M&A of their ENT clinic, and for potential acquirers. We will explain specialized practical points such as countermeasures for seasonal fluctuations, equity interests and member changes in medical corporations, medical fee revisions, and tax treatment.
Management Characteristics of ENT Clinics and Trends in Sale Backgrounds
The management of ENT clinics is characterized by significant “seasonal fluctuations (seasonal variations)” where patient numbers surge during spring (February-April) when cedar and cypress pollen allergies are prevalent, and in winter (November-January) when infections like influenza and common colds increase, while patient visits decrease from summer to autumn. These management characteristics are extremely important points in valuing and negotiating the sale of a clinic through M&A.
For sellers wishing to sell (transferring party), with the increasing need for third-party succession due to aging and lack of successors, many wish to sell early due to the heavy physical and mental burden during peak seasons. On the other hand, for buyers (acquiring party), the focus of the acquisition decision is whether stable revenue can be achieved throughout the year (year-round patient acquisition), not just the cash flow during peak seasons. Generally, year-round treatments such as sublingual immunotherapy, long-term management of allergic diseases, and strengthening the pediatric ENT field tend to be evaluated as strengths supporting year-round patient acquisition.
Legal Systems and Valuation Issues of Equity Interests in Medical Corporation Sales
When an ENT clinic operates as a medical corporation, the succession scheme differs significantly depending on the type of corporation (with or without equity interests). For “medical corporations with equity interests” (transitional medical corporations) established before May 2007, the valuation of equity interests is calculated based on net assets. Therefore, for clinics with significant retained earnings, the valuation amount can become high, increasing the burden of financing for the acquirer and the tax on capital gains.
On the other hand, in “medical corporations without equity interests” (such as those adopting a fund system), management rights are transferred not by selling equity interests, but through the process of changing members and directors (member succession). In this case, it is necessary to properly handle the repayment of contributed funds and the design of executive retirement benefits. In practice, succession schemes are designed according to individual circumstances, such as succession involving a transition from a corporation with equity interests to one without, or reducing the valuation of equity interests by utilizing retirement benefits.
| Item | Medical Corporation with Equity Interests | Medical Corporation without Equity Interests |
|---|---|---|
| Method of Succession | Transfer of equity interests (e.g., paid transfer) | Member change, fund repayment/contribution, director appointment |
| Transfer of Property Rights | Sale proceeds are transferred as consideration for equity transfer | In principle, no equity interests; adjusted through retirement benefits, etc. |
| Tax Issues | Capital gains tax (approx. 20%), risk of gift tax recognition | Tax on executive retirement income (retirement income deduction applicable) |
Impact of Medical Fee Revisions and Facility Standards on ENT M&A
The management of ENT clinics is strongly influenced by medical fee revisions, which occur every two years, and the progress of regional medical plans. In particular, the calculation requirements for frequently performed procedures in ENT (e.g., nebulizer treatments, myringotomy, nasal suction) and additions for pediatric care and online consultations directly impact clinic profitability. Depending on the content of the medical fee revisions, there may be a risk of reduced revenue if the current style of practice is maintained, so revision trends must be incorporated into post-succession business plans.
Furthermore, maintaining and transferring facility standards is also an important issue. For example, it is necessary to confirm in advance whether facility standards for audiological tests and sublingual immunotherapy for Japanese cedar pollinosis can be claimed immediately after succession. In the case of succession from a sole proprietorship (using a scheme of new establishment notification and cancellation notification), facility standards are not automatically transferred, and the acquirer must file new notifications. Therefore, close coordination with the public health center and regional bureau of health and welfare is required to avoid any gap in medical fee claims.
Tax Treatment in Sale Procedures and the Mechanism of Capital Gains Tax
Taxation in medical succession is highly complex, and the types of taxes applied vary depending on the scheme. In the case of a business transfer of a private clinic, income tax and resident tax (e.g., capital gains tax) are levied on the capital gains. If real estate (land/buildings) or goodwill (noren) are included in the transferred assets, the key point is whether the basis for calculating their valuation is appropriate.
In the case of transferring equity interests in a medical corporation, similar to stock transfers, a separate filing tax rate of generally 20.315% (income tax 15.315%, resident tax 5%) is applied. Furthermore, a specific tax rule for medical institutions is the applicability of the “Special Provision for Income Calculation of Social Insurance Medical Fees (Article 26 of the Law for Special Provisions Concerning Taxation)”. This system allows for an estimated calculation of expenses when social insurance medical fees are less than 50 million yen and total medical income is less than 70 million yen. However, caution is advised as this special provision may no longer apply due to business expansion after succession or the introduction of private-pay services (e.g., private portions of sublingual immunotherapy, cosmetic ENT services).
This special provision significantly reduces the tax burden for private clinics and some small corporations. However, if medical income exceeds 70 million yen after acquisition due to factors such as “expansion of consultation hours by increasing the number of doctors” or “increase in patient numbers due to the introduction of new examination equipment,” taxation will switch to actual expenses. When formulating a business plan, it is recommended to simulate the increased tax burden in advance in case the special provision is no longer applicable (※ actual applicability varies by case).
Specific Process for ENT Clinic Sale and Succession
To smoothly proceed with a clinic sale, legal procedures, financial valuation, and administrative procedures must be executed systematically. The general succession process is outlined below.
-
1. Sale Preparation & Chart Analysis
Organize financial statements for the past 3-5 years, analyze monthly patient numbers and claims data to visualize seasonal fluctuation trends.
-
2. Matching & Negotiation of Terms
Meet with potential acquirers to negotiate terms such as the continuation of the treatment policy, employment of staff, and sale price.
-
3. Letter of Intent (LOI) & Due Diligence (DD)
After signing the LOI, the acquiring party conducts a detailed investigation of financial, tax, legal, labor, and medical practice aspects.
-
4. Final Agreement & Administrative Procedures
Conclude the sale agreement and simultaneously proceed with administrative procedures such as submitting notifications to the public health center and applying for designation as an insured medical institution to the regional bureau of health and welfare.
-
5. Succession & Handover Period
Facilitate a smooth transition of operations through the migration of medical chart data, notification to patients, and a period of co-consultation by the transferring physician.
Due Diligence Checkpoints for Potential Acquirers
When considering the acquisition of an ENT clinic, meticulous due diligence (DD) is indispensable to avoid failure. Because it is a specialty with seasonal fluctuations, it is necessary to analyze not only the number of claims in a single month but also the monthly patient numbers and average claim amounts over the past several years in detail.
In particular, the condition of medical equipment such as nebulizers, remaining lease balances, and the risk of staff turnover (especially experienced staff like clerks and nurses who can provide prompt assistance with ENT-specific procedures) can have a significant impact on clinic operations after succession. It is common to focus on checking the following items.
-
✔
Seasonal Fluctuation Data for Patient Numbers: Monthly claims, average customer spending, and daily average patient numbers for the past 3 years. -
✔
Condition of Medical Equipment: Legal useful life and lease contract details for equipment such as fiber scopes, audiometers, and nebulizers. -
✔
Staff Employment Contracts: Intention to continue working after succession, status of provision for retirement benefits, and any unpaid overtime. -
✔
Facility Standards and Permits: Confirmation of facility standards requiring reapplication at the time of succession (e.g., for sublingual immunotherapy, examination add-ons). -
✔
Competitors and Regional Medical Plans: Situation of nearby competing clinics and future projections for ENT demand in the region.
The sale and business succession of ENT clinics require specialized knowledge different from general corporate M&A, due to the difficulty in evaluating revenue associated with seasonal fluctuations, unique legal procedures for medical corporations, and special tax provisions. M&A Medical (operated by CentralMedience Co., Ltd. / Certified M&A Support Institution by the Small and Medium Enterprise Agency) offers specialized advisors well-versed in the medical industry who will provide optimal succession schemes tailored to the individual circumstances of clinic directors considering a sale and doctors/corporations wishing to acquire. Initial consultations are free, so please feel free to contact us.
For Medical Succession Consultations, Contact M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As a Certified M&A Support Institution by the Small and Medium Enterprise Agency, we support the success of sales for clinics and medical corporations struggling with a lack of successors, as well as strategic acquisitions, on a success fee basis.
- Initial Consultation and Preliminary Appraisal are Free
- No Retainer or Monthly Fees (Success Fee Only)
- Strict Confidentiality (Proceeding under NDA)
- Support Available Nationwide (All 47 Prefectures) and for All Medical Specialties
Please consult with us early, even if you are only interested in understanding market value, have no successor, or are considering joining a group.